What is NewDays?
NewDays operates at the intersection of artificial intelligence and neurology, providing a comprehensive platform for cognitive health management. The company distinguishes itself by offering a hybrid model that pairs patients with cognitive clinicians for telehealth consultations while simultaneously deploying an AI-driven companion, Sunny, to facilitate personalized brain exercise regimens. By digitizing the therapeutic process, NewDays addresses the scalability challenges inherent in traditional cognitive care, positioning itself as a leader in the emerging field of digital therapeutics. The platform's ability to deliver consistent, data-backed cognitive homework represents a significant shift in how mental and neurological health is managed outside of clinical settings, offering a scalable solution for patients seeking accessible, high-quality care.
How much funding has NewDays raised?
NewDays has raised a total of $20.5M across 1 funding round:
Seed
$7M
Seed (2025): $7M with participation from General Catalyst and Madrona Venture Group
Key Investors in NewDays
General Catalyst
General Catalyst operates as a venture capital firm focused on identifying and supporting transformational business opportunities across multiple sectors and stages.
Madrona Venture Group
Founded in 1995, Madrona Venture Group is a venture capitalist investment company including consumer internet, commercial software, and services.
What's next for NewDays?
Following this major enterprise-level funding, NewDays is expected to focus on expanding its clinical network and refining the algorithmic capabilities of its AI companion. The strategic infusion of capital will likely be directed toward enhancing the platform's diagnostic accuracy and broadening its reach into new patient demographics. As the company transitions from its initial development phase into a period of rapid scaling, the focus will shift toward establishing long-term partnerships with healthcare providers and insurance networks. By leveraging the expertise of its backers, NewDays is poised to solidify its market position, potentially setting a new standard for how AI-integrated cognitive health services are delivered and reimbursed in the modern healthcare landscape.
See full NewDays company page
